Three Dividend Kings Pull Back Amid AI Selloff, Offering Entry for Long-Term Investors

Three Dividend Kings Pull Back Amid AI Selloff, Offering Entry for Long-Term Investors
Published on: Nov 19, 2026

Three U.S. stocks with at least 50 years of consecutive dividend increases have retreated from their 52-week highs as a selloff in artificial intelligence shares roils the broader market, creating a buying window for investors seeking steady, cross-cycle returns.

Volatility has gripped U.S. equities in recent sessions, with high-flying AI names leading declines and richly valued growth stocks facing sharp valuation compression. Risk appetite has cooled materially, pushing capital away from speculative growth bets and toward defensive assets with reliable cash flows, proven earnings and long track records of payout growth.

The retreating names belong to the elite group of Dividend Kings — companies that have raised their annual dividends for 50 or more straight years. Only about 59 U.S. issuers qualify for the designation, a cohort known for delivering robust long-term total returns driven by both share price appreciation and dividend payments. While the stocks rarely trade at steep discounts, recent pullbacks have put three names within reach: Abbott Laboratories (ABT), McDonald’s Corp. (MCD) and Tennant Co (TNC).

Abbott Laboratories, a diversified healthcare company, has paid quarterly cash dividends for 102 years and lifted them for 54 consecutive years. It carries a forward dividend yield of about 2.3%, with an average annual payout growth rate of roughly 9.4% over the past five years. A planned spinoff of its nutrition business, announced last month, may act as an additional share price catalyst. The segment, which produces nutritional supplements and infant formula, has grappled with softening sales and legal headwinds. Shedding the unit would let Abbott refocus on its faster-growing medical technology operations, including medical devices and diagnostics. The stock trades at 18 times forward earnings, well below the 20-plus multiples common among comparable medical device peers. Market observers note a valuation re-rating, paired with stronger earnings and dividend growth once the spinoff closes, could deliver robust total returns over the coming years.

McDonald’s shares slumped earlier this year, as persistent inflation strained consumer budgets and fueled worries about the fast-food giant’s long-term growth outlook. The stock has since bounced back following its third-quarter 2026 earnings release earlier this month, when the company reported better-than-expected profit, offered upbeat commentary on U.S. restaurant performance and laid out fresh details on its turnaround strategy. Some market participants caution the recent rebound may have come too fast, but if operational improvements translate into sustained financial progress, the Dividend King still has upside.

McDonald’s has raised its dividend for 50 straight years, backed by a steady stream of franchise royalties and rental income. It carries a forward dividend yield of 2.8%, with an average annual payout growth rate of 7.3% over the past five years. Shares currently change hands at about 20 times forward earnings, compared with their historical range of 25 to 30 times, leaving room for multiple expansion if execution improves.

Tennant Co., a maker of floor cleaning and maintenance equipment, is a low-profile industrial name with 55 consecutive years of dividend increases. The company rolled out its latest payout hike this month, boosting its quarterly cash dividend by 5% to 32.5 cents per share. That puts its forward dividend yield at around 1.75%, with a five-year average annual growth rate of 6.1%. Despite its old-economy roots, Tennant is leaning into automation with robotic floor-cleaning equipment, a pivot already reviving top-line growth. Revenue climbed 6% last quarter, while orders advanced 9.5%. Near-term costs from ERP system upgrades and robotics investment have pressured earnings growth, though those headwinds are widely seen as temporary. The stock trades in the mid-$70s, down from peaks above $100 in mid-2024.

All three companies boast dividend growth streaks that have survived multiple economic cycles. Their recent share price pullbacks, combined with company-specific fundamental catalysts, present a favorable entry point for investors targeting durable long-term returns. Against a backdrop of shifting market leadership, Dividend Kings that blend defensive income characteristics with embedded growth drivers remain well-positioned in investor portfolios.

Consumer Products and Services Contrarian Investing Dividend Yielding Stocks Medical Device